Abstract
Trial closure refers to the activities that take place in preparation for the cessation of trial recruitment through to archiving of the trial. Trial closure can be notionally divided into five stages: End of Recruitment; End of Trial Intervention; End of Trial; Trial Reporting and Publishing; and Archiving. The length and scheduling of each stage of trial closure is determined by the trial design and operating model. As trial closure approaches there is an increased emphasis on monitoring and controls to ensure the correct number of participants is recruited and data collection and cleaning in preparation for final database lock and analysis is complete. The End of Trial is a key ethical and regulatory milestone defined in the approved trial protocol and has associated time-dependent notification and reporting requirements to the independent ethics committee and, for regulated trials, the regulator(s). Key steps of trial closure, reporting, publishing, and data sharing are important mechanisms to support transparency in clinical trials. A Trial Closure Plan can be used to support the activities that ensure appropriate control over the final stages of the trial.
Similar content being viewed by others
References
Clinical Trials.gov (2017) FDA 42 CFR Part 11 Final Rule for Clinical Trials Registration and Results Information Submission. Available via https://prsinfo.clinicaltrials.gov/ Accessed 17 October 2020
European Commission (2017) Summaries of Clinical Trial Results for Laypersons. Available via https://ec.europa.eu/health/sites/health/files/files/eudralex/vol-10/2017_01_26_summaries_of_ct_results_for_laypersons.pdf Accessed 17 October 2020
European Medicines Agency (2016) Clinical data publication. Available via https://www.ema.europa.eu/en/human-regulatory/marketing-authorisation/clinical-data-publication Accessed 17 October 2020
International Committee of Medical Journal Editors (2019) Clinical Trials Registration and Data Sharing Policies. Available via http://www.icmje.org/recommendations/browse/publishing-and-editorial-issues/clinical-trial-registration.html Accessed 17 October 2020
International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use (ICH) (2016) Guideline for Good Clinical Practice. Available via https://www.ich.org/page/efficacy-guidelines Accessed 17 October 2020
Medical Research Council/Department of Health/Medicines and Healthcare products Regulatory Agency (2012) Risk-adapted approaches to the management of clinical trials of investigational medicinal products. Available via https://assets.publishing.service.gov.uk/government/uploads/system/uploads/attachment_data/file/343677/Risk-adapted_approaches_to_the_management_of_clinical_trials_of_investigational_medicinal_products.pdf Accessed 17 October 2020
Medicines and Healthcare products Regulatory Agency (2018) ‘GXP’ Data Integrity Guidance and Definitions. Available via https://mhrainspectorate.blog.gov.uk/2018/03/09/mhras-gxp-data-integrity-guide-published/ Accessed 17 October 2020
MRC Methodology Hubs for Trials Methodology Research (2015) Good Practice Principles for Sharing Individual Participant Data from Publicly Funded Clinical Trials. Available via https://www.methodologyhubs.mrc.ac.uk/files/7114/3682/3831/Datasharingguidance2015.pdf Accessed 17 October 2020
Official Journal of the European Union (2010) Detailed guidance for the request for authorisation of a clinical trial on a medicinal product for human use to the competent authorities, notification of substantial amendments and declaration of the end of the trial. Available via https://ec.europa.eu/health/documents/eudralex/vol-10_en. Accessed 17 October 2020
UK Health Research Authority (2014) Information for participants at the end of a study: Guidance for Researchers. Available via https://www.hra.nhs.uk/media/documents/information-participants-end-study-guidance-researchers.pdf Accessed 17 October 2020.
World Health Organisation (2012) International Standards for Clinical Trial Registries WHO Public Registries. Available via https://apps.who.int/iris/bitstream/handle/10665/76705/9789241504294_eng.pdf?sequence=1 Accessed 17 October 2020
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Section Editor information
Rights and permissions
Copyright information
© 2021 Springer Nature Switzerland AG
About this entry
Cite this entry
Booth, G. (2021). End of Trial and Close Out of Data Collection. In: Piantadosi, S., Meinert, C.L. (eds) Principles and Practice of Clinical Trials. Springer, Cham. https://doi.org/10.1007/978-3-319-52677-5_41-1
Download citation
DOI: https://doi.org/10.1007/978-3-319-52677-5_41-1
Received:
Accepted:
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-52677-5
Online ISBN: 978-3-319-52677-5
eBook Packages: Springer Reference MathematicsReference Module Computer Science and Engineering